Pfizer Accupril Patent Invalid Due To Inequitable Conduct, Lawsuit Alleges

Pfizer hid prior art from Patent & Trademark Office in effort to prolong patent protection for Accupril, a recent lawsuit against the company alleges

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet